An 3rd-party provider of OSB (order/ship/bill), logistics and distribution of pharmaceuticals, dietary supplements, medical devices, and a full range of other products for the health sector.
The owner and commercial distributor of a number of branded as well as generic pharmaceuticals in addition to a portfolio of nutraceuticals and OTC consumer health products.
Had quickly become a leader in the generic pharmaceutical market in Belgium. In 2001 the company listed on the Euronext stock exchange and was sold in 2005 to a strategic buyer.
Provides high-end products, services and solutions for treatment of musculoskeletal trauma. The company's complete portfolio allows surgeons to treat all fractures of upper and lower extremities, whether with plates & screws, intramedullary devices or external fixators.
MD Medical Diagnostics
Using ultrasound technology as a basis for detecting cancer, the company's revolutionary software is able to provide a 3-D overlay with visual analysis of imaging, showing cancer locations and sizes at a greater accuracy and much cheaper than other available technologies.
A marketing stage biotechnology company that develops and markets a unique surgical sealant, as well as a suite of other plasma-derivative products. Omrix IPO'd on the NASDAQ in 2006 and was sold to Johnson & Johnson in 2008.
A company founded for the purpose of developing own-branded as well as marketing generic fertility products for the European markets.